Drug Discovery App CS WP

  1. BioPharma Expands 3D Structure Portal 9/30/2022

    Learn about the competitive advantage that helped a research-based biopharmaceutical company close the communication gap between medicinal chemists and modelers.

  2. Smart Data For Smart Decisions 9/29/2022

    Learn how quality of data directly impacts decision-making efforts along with factors to ensure smart data and the value of an open and flexible integration platform.

  3. Creating A Scalable Data Science Framework 9/29/2022

    Explore new methodologies and approaches to improve R&D efficiency and productivity to lower costs and shorten time to market.

  4. The Journey To AAV Production In Suspension – Scaling-Up Your Process 9/27/2022

    We present a simple protocol for scaling up AAV production using HEK293 host cells cultured in suspension and under serum-free conditions.

  5. Advancing A Cell Therapy Drug To The Clinic: Safety Tox Package 9/26/2022

    Cytopeutics, a provider of mesenchymal stem cells (MSC) for clinical trials and treatment, needed to conduct safety and tumorigenicity studies in appropriate animal models for its hMSC product.

  6. Optimizing Lipid Formulations For Targeted RNA-LNP Applications 9/13/2022

    Learn about the considerations and challenges of using ionizable lipids, including the 5 types of lipids used for RNA delivery.

  7. Process Development Considerations For RNA-LNP Therapeutics 9/13/2022

    Here, we highlight three important process considerations across the RNA-LNP manufacturing workflow which includes limit size behavior, in-line dilution and downstream tangential flow filtration (TFF).

  8. Key Stages In mRNA-Based Therapeutic Development 9/13/2022

    Learn how planning a product development strategy early on with a technology partner who has deep expertise and technical knowledge of genomic medicines can address uncertainties from the outset.

  9. Expansion Of Porcine SK-RST Cells On Microcarriers Via Serial Passage In Stirred Vessels 9/7/2022

    By performing a small-scale study with multiple microcarrier types and medias we identify the best microcarrier and media for the expansion of porcine SK-RST cells via microcarrier-based serial passage in stirred vessels.

  10. SPR Assays To The Assess Similarity Between Innovator And Biosimilar Versions of Nivolumab (Opdivo®) 9/2/2022

    Learn more about developed and qualified SPR assays to characterize the binding and affinity of biosimilar and innovator nivolumab for all seven Fc gamma receptors, FcRn and PD-1.